On the effect of amantadine on monoamines and their metabolites in the brain and cerebrospinal fluid.
D000368:Aged; D000547:Amantadine / Q000627:therapeutic use; D000818:Animals; D001921:Brain / Q000378:metabolism; D001923:Brain Chemistry / Q000187:drug effects*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009638:Norepinephrine / Q000032:analysis; D010300:Parkinson Disease / Q000134:cerebrospinal fluid* / Q000188:drug therapy; D010648:Phenylacetates / Q000378:metabolism*; D051381:Rats
D010648:Phenylacetates; D000547:Amantadine; D009638:Norepinephrine